These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1670904)

  • 1. Intragastric pH and control of peptic ulcer bleeding.
    Arora A; Tandon RK; Acharya SK
    Am J Gastroenterol; 1991 Jan; 86(1):116-7. PubMed ID: 1670904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histamine H2 receptor antagonists and upper digestive hemorrhage].
    Blanchi A; Soulé JC
    Gastroenterol Clin Biol; 1985 Feb; 9(2):153-61. PubMed ID: 2858426
    [No Abstract]   [Full Text] [Related]  

  • 3. A dosage alternative for H2-receptor antagonists--constant infusion.
    Siepler JK
    Clin Ther; 1986; 8 Suppl A():24-33. PubMed ID: 2878728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
    Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
    J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of intravenous H2-receptor antagonists in a tertiary care hospital.
    Dettmer RM; Riley TH; Byfield F; Green PH
    Am J Gastroenterol; 1999 Dec; 94(12):3473-7. PubMed ID: 10606306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
    Moore JG
    DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative treatment of ulcer hemorrhage with histamine H2 antagonists].
    Grigor'ev PI; Grinberg AA; Toguzova DA; Iakovenko AV; Lopatina IV
    Khirurgiia (Mosk); 1997; (5):63-5. PubMed ID: 9297029
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous omeprazole after endoscopic treatment of bleeding peptic ulcers.
    Palmer KR
    Gut; 2001 Nov; 49(5):610-1. PubMed ID: 11600458
    [No Abstract]   [Full Text] [Related]  

  • 10. The predictable effect that renal failure has on H2 receptor antagonists--increasing the half-life along with increasing prescribing errors.
    Boudville N
    Nephrol Dial Transplant; 2005 Nov; 20(11):2315-7. PubMed ID: 16077140
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of omeprazole and placebo for bleeding peptic ulcer.
    Srinath C
    Trop Gastroenterol; 1997; 18(3):115-6. PubMed ID: 9385855
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience in clinical use of quamatel in upper gastrointestinal hemorrhage].
    Shlevkov BA; Abramova LA; Toguzova DA
    Khirurgiia (Mosk); 2001; (7):45-8. PubMed ID: 11521310
    [No Abstract]   [Full Text] [Related]  

  • 13. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of histamine H2 receptor blockaders in gastroenterology].
    Waldum HL; Petersen H
    Tidsskr Nor Laegeforen; 1983 Apr; 103(12):980-3. PubMed ID: 6136102
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of upper digestive hemorrhage in severely ill patients].
    Faintuch J
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(3):91-4. PubMed ID: 1983765
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of the use of somatostatin (VAL 787) in the treatment of upper digestive hemorrhage].
    Dal Monte PR; D'Imperio N; Formica G; Macchia S; Piemontese A; Sarti F; Spongano P
    Minerva Dietol Gastroenterol; 1989; 35(4):261-4. PubMed ID: 2576114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-H2 and omeprazole in brief therapy of peptic ulcer].
    Piai G; Sabbatini F; Mazzacca G
    Ann Ital Chir; 1990; 61(1):11-4. PubMed ID: 1978622
    [No Abstract]   [Full Text] [Related]  

  • 18. Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?
    Lin HJ; Tseng GY; Hsieh YH; Perng CL; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 1999 Nov; 94(11):3184-8. PubMed ID: 10566712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for pH control in upper gastrointestinal bleeding.
    Brunner G; Luna P; Thiesemann C
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():47-50. PubMed ID: 7495943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
    Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
    Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.